EN DE
STOCK COMPARISON

Merck KGaA vs Strides Pharma Science: Fair Value & Quality

Both stocks run through our valuation models. Here is how Merck KGaA (MRK) and Strides Pharma Science (STAR) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Merck KGaA trades at €134 versus a fair value of €109 (-19%), while Strides Pharma Science trades at ₹1,203 versus ₹888 (-26%).
Merck KGaA
MRK.XETRA · EUR · Health Care
-19%
upside to fair value
overvalued
Price€134
Fair Value€109
Quality62/100
Strides Pharma Science
STAR.NSE · INR · Health Care
-26%
upside to fair value
overvalued
Price₹1,203
Fair Value₹888
Quality56/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Merck KGaAStrides Pharma Science
Valuation
24.1×P/E (TTM)20.3×
3.14×P/S (TTM)2.32×
2.30×P/B3.63×
12.9×EV/EBITDA12.6×
2.76×PEGn/a
−18.9%Fair value upside−26.2%
1.7%Dividend yield0.4%
€2.20Dividend per share₹5.00
Profitability
18%Operating margin14%
1.07×EBIT margin trend (5Y)1.55×
9%Return on equity20%
5%Return on assets7%
Growth
-3%Revenue growth (YoY)11%
-1.7%Avg. growth/yr (3Y)9.8%
3.8%Avg. growth/yr (5Y)8.2%
+7.3%Value creation/yr+31.6%
Balance & size
15.5×Interest coverage (EBIT/interest)4.0×
0.36×Debt / equity0.18×
$66BMarket cap$1B
mixedGrowth qualityexpensive

Strides Pharma Science leads: 6 to 9 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Merck KGaAof which business quality 61 · market factors 66 Strides Pharma Scienceof which business quality 53 · market factors 73
ProfitabilityMargins and returns on capital today
41
54
Quality GrowthAre margins and returns improving?
40
60
CashflowEarnings quality: real cash, not paper profit
57
26
Fin. StrengthBalance sheet, leverage, solvency risk
76
52
InvestmentDisciplined investing over empire-building
80
65
Low VolatilityCalm price path (market factor)
72
75
MomentumPrice trend over the last 3–12 months (market factor)
61
65
52W MomentumDistance to the 52-week high (market factor)
68
86
Net IssuanceShare count: buybacks or dilution?
82
77

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMerck KGaAPrice €134Strides Pharma SciencePrice ₹1,203
DCF Models-20%below the price€107-20%below the price₹961
Earnings-Based-60%below the price€53.25-45%below the price₹657
Dividend Discount-70%below the price€40.71-96%below the price₹53.57
Multiples-12%close to the price€118-3%close to the price₹1,161
Asset-Based-67%below the price€44.06-81%below the price₹226
Growth DCF-29%below the price€94.57-42%below the price₹700
Economic Profit-50%below the price€66.44-51%below the price₹595
Growth Earnings-14%close to the price€115-7%close to the price₹1,120
Minimum-70%below the price€40.71-96%below the price₹53.57
Maximum-12%close to the price€118-3%close to the price₹1,161
Median-40%below the price€80.50-44%below the price₹679
Geometric mean-45%below the price€73.75-58%below the price₹504

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Merck KGaA: 23 of 26 models see the stock below the current price.

Strides Pharma Science: 20 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Merck KGaA
Price €134
Fair Value €109
Bear €59.91Bull €150
Strides Pharma Science
Price ₹1,203
Fair Value ₹888
Bear ₹461Bull ₹1,456

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Merck KGaA · Health Care

Quality score62 · above median
Fair value upside-19% · above median

Strides Pharma Science · Health Care

Quality score56 · above median
Fair value upside-26% · below median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Merck KGaA trades at €134 versus a fair value of €109 (-19%), while Strides Pharma Science trades at ₹1,203 versus ₹888 (-26%).

Merck KGaA has the higher quality score (62/100).

Open Merck KGaA live analysis →
Merck KGaA · Strides Pharma Science

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Merck KGaA

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Strides Pharma Science

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.